Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 76Polycystic Ovary Syndrome 3Neoplasms, Hormone-Dependent 3Neoplasm Metastasis 3Arthralgia 3Advanced Breast Cancer 3Osteoporosis 2Fractures, Bone 2Endometrial Neoplasms 2Carcinoma, Lobular 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Cancer Female 2Sexuality 1Sexual Dysfunctions, Psychological 1Neurotoxicity Syndromes 1Luminal B/HER2-negative Breast Cancer 1Leiomyoma 1Infertility 1Hot Flashes 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Breast Carcinoma 1Hormone Receptor Positive Advanced Breast Cancer 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Fatigue 1Estrogen Receptor and/or Progesterone Receptor Positive 1Endometrial Stromal Tumors 1

Interventions

Zoledronic Acid 6Risedronic Acid 5Calcium 4Vitamin D 3Denosumab 3Letrozole 2Toremifene 1Radiography, Panoramic 1Nutrition Assessment 1Kyphoplasty 1Ibandronic Acid 1Health Promotion 1Geritol 1Exercise Movement Techniques 1Exercise 1Cholecalciferol 1Calcium Carbonate 1Aromatase Inhibitors 1Anastrozole 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Diseases, Metabolic × Aromatase Inhibitors × Clear all
NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡